Wordt geladen...
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
BACKGROUND: The administration of rituximab (RTX) in vivo results in B-cell depletion, but evidence for multiple mechanisms of action have been reported. Surprisingly, B cell depletion produced a response in patients with polymyositis, which is characterized as a T cell-mediated autoimmune disorder...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2912795/ https://ncbi.nlm.nih.gov/pubmed/20618995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-11-157 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|